• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » GE HealthCare launches new AI-enhanced ultrasound for women’s health

GE HealthCare launches new AI-enhanced ultrasound for women’s health

April 18, 2024 By Sean Whooley

GE HealthCare Voluson 20
The Voluson Signature 20 system. [Image from the GE HealthCare website]
GE HealthCare (Nasdaq: GEHC) announced today that it launched the Voluson Signature 20 and 18 ultrasound systems for women’s health imaging applications.

Chicago-based GE HealthCare designed the systems to integrate AI, advanced tools and an ergonomic design. They speed exam time for clinicians while delivering a clearer picture of various conditions impacting women’s health. The latest systems combine high-performance hardware with flexible, scalable software to help increase confidence in diagnostic and treatment decisions.

The company said in a news release that AI-enabled ultrasound technologies support clear, quick and confident diagnoses. This latest launch helps to address patient demand and reduce staffing burdens by giving clinicians these tools. Dr. Ben Csapo, a maternal fetal medicine specialist in Graz, Austria, said AI enables a “new era of ultrasound scanning.”

“The new Voluson Signature series features innovative tools clinicians can rely on, and the automated functions help reduce work stress and improve workflows,” said Csapo.

Features of the new GE HealthCare imaging tech

GE HealthCare says its latest AI-powered capabilities enable a number of efficiencies across women’s healthcare settings. Features include voice commands and the SonoLyst suite of AI tools. SonoLyst tools identify fetal anatomy and annotate and measure where applicable. This can reduce the time to complete second trimester exams by up to 40%, the company said.

The SonoPelvicFloor feature simplifies assessments of the pelvic floor and speeds up exams as well. It automates plane alignment and measurements for an up to 76% keystroke reduction. Meanwhile, Fibroid Mapping uses AI to standardize and streamline fibroid documentation by mapping, measuring and classifying fibroids. FetalHS simplifies and speeds fetal heart assessments by up to 48% with step-by-step, AI-driven guidance for identifying normal fetal heart anatomy.

GE HealthCare also integrated the technology with its Vscan Air CL wireless dual probe. With a flexible, wireless workflow, users gain a wider range of motion.

“Next-level image clarity can help clinicians detect fetal abnormalities and hard-to-spot gynecological emergencies or conditions like endometriosis earlier, which can make a big difference in a patient’s treatment plan and overall health,” said Gerald Seifriedsberger, GM, Women’s Health Ultrasound, GE HealthCare. “With proven time-saving AI-driven applications, and advanced automation features that simplify exams, we’re providing technology that can help enhance ease of use and provide clearer images – helping clinicians power through demanding workflows faster while delivering greater consistency and accuracy, ultimately helping deliver better health outcomes for women.”

Filed Under: Artificial Intelligence (AI), Business/Financial News, Featured, Health Technology, Imaging, Software / IT, Ultrasound, Women's Health Tagged With: GE Healthcare

More recent news

  • Former Shockwave Medical CEO joins Solenic Medical’s board
  • Anaconda Biomed brings in $56 million
  • Precision Neuroscience raises $250M in Series D for its BCI
  • Fresenius discontinuing Chinese sales of 4008A hemodialysis system
  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy